Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Interim Report April - December 2021

A historically strong quarter driven by sales of home tests October - December · Consolidated sales during the third quarter, October to December amounted to SEK 117.6 (29.6) million. Adjusted for non-recurring sales the revenue amounted to 33.1 (23.4) MSEK, an increase of 41.4%. · Gross profit amounted to SEK 32.5 (10.5) million for the quarter, an increase of 209.2%. · EBIT for the quarter was SEK 18.0 (2.4) million. · Earnings per share were SEK 0:59 (0:07) for the quarter. · Cash flow from operating activities amounted to SEK 12.4 (-5.7) million for the quarter. ·

Intervacc applies for a Permit for Sale and Distribution of Strangvac in the U.S.

Stockholm, February 16, 2022 - Intervacc AB (publ) announces that the Company’s application for a Permit for Sale and Distribution of Strangvac in the U.S. has been submitted to the U.S. Department of Agriculture (USDA). Intervacc is seeking approval for Strangvac, a vaccine against the highly contagious equine disease strangles that affects horses worldwide. Strangvac has been approved for use in the European Union, the United Kingdom, Norway, and Iceland since the autumn of 2021. “The number of horses in the United States is estimated to be around 10 million representing the largest

Full Year Report January – December 2021

Highlights for the full year and the fourth quarter · Record full year sales and operating profit with double-digit growth in both revenues and earnings in local currencies across all product segments. · Impressive performance for the Smokefree product segment with strong growth in both the US and Scandinavia. Growing demand for natural leaf cigars drove the robust full year local currency financial performance for the Cigars product segment. Strong underlying performance for the Lights product segment. · Strong financial performance in the fourth quarter driven by Smokefree with

Ahlstrom-Munksjö: Ahlstrom-Munksjö Holding 3 Oy pre-announces its sales and comparable EBITDA for 2021

AHLSTROM-MUNKSJÖ OYJ PRESS RELEASE FEBRUARY 16, 2022 at 09:05 EET Ahlstrom-Munksjö Holding estimates that pro forma1 net sales increased to EUR 3,076.6 million (2,683.3) and pro forma1 comparable EBITDA to EUR 398.3 million (334.2) in 2021. Ahlstrom-Munksjö Holding further estimates that reported net sales were EUR 2,814.2 million and operating result EUR 72.3 million in 2021. These figures are preliminary in nature and the actual results for this period may differ from these preliminary estimates. Ahlstrom-Munksjö's parent company Ahlstrom-Munksjö Holding 3 Oy will publish its

Advania to acquire Valtti, a Finnish full-service IT-provider from Adelis Equity Partners

With the acquisition of Valtti, Advania will leverage the combined future-ready suite of products and services in Finland to help customers on their digital journey. The acquisition underpins Advania’s ambition to create the preferred IT-services provider in Northern Europe with a holistic offering to their existing and new customers. Helsinki, Finland Key transaction highlights · Advania, a portfolio company of Goldman Sachs Asset Management, has reached a definitive agreement to acquire Valtti, from Adelis Equity Partners Fund II AB (Adelis), management and other

Saphnelo approved in EU for SLE

16 February 2022 07:00 GMT Saphnelo approved in the EU for the treatment of moderate to severe systemic lupus erythematosus Saphnelo is a first-in-class type I interferon receptor antibody and the only new medicine in over a decade for patients with systemic lupus erythematosus AstraZeneca's Saphnelo (anifrolumab) has been approved in the European Union as an add-on therapy for the treatment of adult patients with moderate to severe, active autoantibody-positive systemic lupus erythematosus (SLE), despite receiving standard therapy. Saphnelo is the first biologic for SLE

The Board of Directors of Alma Media Corporation has decided on new periods under the long-term share-based incentive schemes for key employees

Alma Media Corporation                Stock Exchange Release 16 February 2022 at 9 p.m. THE BOARD OF DIRECTORS OF ALMA MEDIA CORPORATION HAS DECIDED ON NEW PERIODS UNDER THE LONG-TERM SHARE-BASED INCENTIVE SCHEMES FOR KEY EMPLOYEES The Board of Directors of Alma Media Corporation has decided on the commencement of a new period under the long-term share-based incentive scheme for senior management. The Board of Directors has further decided on the commencement of a new period under the performance-based share-based incentive scheme aimed at middle management and selected key employees.

Hemsö acquires nursing home in Germany

Hemsö is expanding its portfolio and acquiring a nursing home in Brandenburg an der Havel in Germany. The investment amount is EUR 19.8 million.The nursing home is located west of Berlin in the state of Brandenburg. The home has 124 beds, comprising 58 single rooms and 33 double rooms. There are also ten assisted-living apartments, 12 intensive care rooms and one physiotherapy unit. “We have broadened our acquisition strategy in recent years to include educational institutions such as schools and sports centres, but our core business in Germany is still health care and elderly care

Volvo Trucks leads the electric truck market in Europe

New statistics show that Volvo Trucks was the market leader for heavy all-electric trucks in Europe 2021 with a market share of 42%. In 2021 the company took orders, including letters of intent to buy, for more than 1,100 electric trucks worldwide.The international trucking industry is undergoing a transformation towards more sustainable transport as sales of heavy battery electric trucks are starting to pick up, with Europe in the lead. An increasing number of heavy all-electric trucks are now running in commercial traffic. Statistics from the market analysis group IHS Markit show that

Invitation to earnings call for Year-end report 2021

The Year-end report 2021 will be published on February 23, 2022, 08.00 (CET), and in conjunction with this, an earnings call will be arranged at 14:00 (CET) the same day. The earnings call will be available afterwards on the company’s website.Presentation material will be available at www.bico.com and the presentation will be held in English. Date: Wednesday, February 23, 2022. 14:00 (CET)For audio: +46 8 502 439 36 Conference-ID: 959 931 880#For video: Video link 

GET GROUP’S SUBSIDIARY GEOTHERMAL DIGITAL ASSETS LIMITED HAS TODAY ISSUED THE WORLD’S FIRST DIGITAL TOKEN WITHIN GEOTHERMAL ENERGY

Digital Geothermal Assets Limited (’DGA’), a wholly owned subsidiary of GET Group AB (publ), has today issued 100 million GET Geo Tokens (‘uGETG’). It is GET Group’s intention to distribute a percentage of the uGETG tokens to its shareholders and list the tokens on the Ultra Exchange.DGA is responsible for the current- and future geothermal digital assets strategy of GET Group. DGA has today issued 100 million uGETG tokens to DGA. It is the world’s first digital token within geothermal energy. The uGETG tokens have a nominal par value of 0.001 Ven per token. The uGETG token is the

Year-end report 2021

Castellum posts its highest earnings ever, and proposes an increased dividend for the 24th consecutive year· Income for 2021 totalled MSEK 6,353 (6,004).  · Income from property management increased by 4% to MSEK 3,522 (3,380), equivalent to SEK 12.45 (12.35) per share.  · Change in value on properties amounted to MSEK 7,185 (3,863) and on derivatives to MSEK 325 (–120).  · Net income for the year amounted to MSEK 11,828 (5,615), corresponding to SEK 41.81 (20.52) per share.  · Long-term net reinstatement value (EPRA NRV) amounted to SEK 251 per share (214), an increase

Safello Publishes Interim Report for Q4 and the Financial Year 2021

Stockholm, 16 February 2022 | Today, Safello Group AB (“Safello”) publishes the company’s interim report for the fourth quarter and the financial year 2021. The report can be found on safello.com/ir. The fourth quarter showed a record net turnover as a result of improved product portfolio and increased development capacity. Net turnover increased by +102% compared with the same period in 2020 and amounted to SEK 215.0 million (106.5). Gross profit in the quarter was SEK 8.9 million (6.0), an increase of +50%. The quarter is characterized by accelerated product development and strong growth

Invitation to presentation of Catena Media’s Q4 results 2021

Catena Media’s Year-End report for the fourth quarter that ended 31 December 2021 will be published in English on Wednesday 23 February at 07:00 CET. Following the release of the report a combined presentation audiocast and telephone conference with the opportunity to ask questions will be held at 09:00 CET on the same day, with CEO Michael Daly and Group CFO Peter Messner presenting the report. The presentation audiocast will be accessible via the following link:https://tv.streamfabriken.com/catena-media-q4-2021 The presentation will also be available on the company’s website:

Ending 2021 above Safeture targets

Interim Report October 1 – December 31, 2021 · Annual recurring revenue (ARR) growth of 35% to 32,2 MSEK. · Recurring revenue in Q4 amount to 7,5 MSEK compared to 5,4 MSEK last year (+38%). · Gross Margin in Q4 improves to 70%. · Increased levels of customer up-sell resulted in a net revenue retention (NRR) of 102,4% · Safeture  won a public procurement regarding travel risk management for the European Central Bank (ECB).Summary of Interim Report The Group Twelve months (2021-01-01 to 2021-12-31) · Net revenue amounted to 26 796 (21

CONCENTRIC INTERIM REPORT JANUARY – DECEMBER 2021

FOURTH QUARTER · Net sales: MSEK 695 (380) – reported sales were up +83% year-on-year. After adjusting for the impact of currency (–2%), Allied Enterprises (+5%) and EMP (+44%), sales on a like for like basis, in constant currency year-on-year were up +36%. · Operating income: Operating income was MSEK 87 (104) generating an operating margin of 12.5% (27.4). After one-off items including costs relating to the acquisition of EMP (MSEK 18) and the closure of Chivilcoy (MSEK 22) Operating income before items affecting comparability was MSEK 127 (99) with a corresponding margin of 18.2%

Report on Operations 2021: Continuous growth and a new Vitrolife

Fourth quarter · Sales of SEK 514 (382) million, corresponding to an increase of 35 percent in SEK. Consumables increased by 9 percent, Genomics 33 percent, Technology decreased by 12 percent. The organic growth was 4 percent. · The acquisition of Igenomix was completed the last day of November and is included as division Genetic Services in December 2021. · Sales in Genetic Services, only for December, were SEK 116 million corresponding to an acquired growth of 30 percent. · Operating income before depreciation and amortization (EBITDA) was SEK 164 million, adjusted for non-

Starbreeze AB (publ) Year-End Report 2021

Fourth quarter 2021 · Net sales amounted to SEK 31.1 million (32.6). PAYDAY accounted for SEK 30.2 million (30.7). · EBITDA* amounted to SEK 15.6 million (5.3). · Amortization, depreciation and impairments amounted to SEK 15.0 million (9.7). · Profit before tax was SEK -13.0 million (-16.4). · Basic and diluted earnings per share were SEK -0.02 (-0.02). Full year 2021 · Net sales amounted to SEK 125.7 million (118.0). PAYDAY accounted for SEK 119.8 million (111.5). · EBITDA* amounted to SEK 6.3 million (49.3). · EBITDA**, adjusted for one-off effects related

Eurocine Vaccines publishes half-year report for July - December 2021

Eurocine Vaccines AB (“Eurocine Vaccines”) hereby publishes the half-year report for July to December 2021. Below is a summary of the report. The full report is available on the Eurocine Vaccines website and as an attachment.2021-10-01– 2021-12-31 (second quarter) · Results after tax for the quarter amounted to -5.3 MSEK (-4.4 MSEK) · Revenues for the quarter amounted to 0 KSEK (67 KSEK) · Earnings per share for the quarter amounted to -0,373 SEK (-0,553 SEK)*   2021-07-01– 2021-12-31 (the period, six months) · Results after tax for

Year-end Report, 31 December 2021

“Major earnings improvement, stronger financial position and increased scope for acquisitions”Andreas Morfiadakis, CEO October – December · Revenue for the quarter was SEK 115.1 million (55.5), up 107 per cent year-on-year. · The Group’s net operating income was SEK 62.9 million (28.9), up 118 per cent over the year-earlier period. · Profit from property management for the quarter was SEK 22.7 million (12.0), up 89 per cent over the year-earlier period. · Changes in the value of investment properties amounted to SEK 303.7 million (148.3) and changes in the value of

The nomination committee for Synsam has been appointed

According to the principles for appointment of the nomination committee in Synsam AB (publ) (the "Company" or "Synsam") for the 2022 annual general meeting, the nomination committee shall be composed of five members: one member appointed by each of the four largest shareholders or shareholder groups in terms of voting rights in the Company per the last business day in January 2022 and who whishes to appoint a member, and the chairman of the board of directors. The nomination committee shall appoint a chairman among its members. The nomination committee for the 2022 annual general meeting

IRRAS AB publishes Year End Report for the period January to December 2021

Sixth Consecutive Quarter of Revenue Growth Posted“The 4th quarter of 2021 served as an encouraging end to an eventful year for our IRRAS team.  Each consecutive quarter of 2021 showed the progress that IRRAS is making toward becoming a leader in neurocritical care, and we are poised to continue this progress into 2022.” “All told, we are pleased with our accomplishments throughout all of 2021.  During the year, our team progressed across all aspects of our business, and these accomplishments resulted in revenue growth of more than 200% during 2021.” Will Martin, President and CEO of

Maria Strandberg new CFO at Castellum

Maria Strandberg has been appointed the new CFO at Castellum AB. She will take office on 1 March.Maria Strandberg comes most recently from the position as Finance Director at Kungsleden, where she has held several executive roles since 2015. She previously worked as an auditor at EY and has a degree in Business Administration. “As CFO and a member of Executive Management, I look forward to creating the best conditions for clear, transparent financial reporting and analysis and to be involved in developing the largest listed commercial property company in the Nordic region,” says Maria

Year-end Report January – December 2021

Kungsleden AB’s year-end report 2021 has been prepared for the purpose of complying with the terms of Kungsleden AB's (publ) bond and loan agreements.The year in brief • Profit from property management increased by 5 per cent to SEK 1,322 million (1,257). The increase is mainly due to higher rental revenue, lower selling and administration costs and improved net financial items. • After investments of SEK 1,307 million (1,395) and positive unrealised changes in value of SEK 5,441 million (948), which corresponds to 13.4 per cent, property value at the end of the year was SEK 47,258

There are no items matching the current filter
There are no more items matching the current filter
Back to top